サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566903

画像誘導放射線治療市場：製品別、手技別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年

Image-Guided Radiation Therapy Market By Product, By Procedure (IMRT, Stereotactic Therapy, Particle Therapy, Others) By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
画像誘導放射線治療市場：製品別、手技別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

画像誘導放射線治療市場

画像誘導放射線治療市場は、2023年に19億米ドルと評価され、2024年から2033年にかけてCAGR 5.7%で成長し、2033年には33億米ドルに達すると予測されています。

画像誘導放射線治療は、がんの治療で頻繁に使用される画像処理プロセスです。この治療法には、MRI、PET、CTスキャンなど複数の画像技術が含まれ、がん細胞を死滅させるための放射線の正確なターゲティングを可能にします。正確なターゲティングは、画像技術によって生成された高画質画像を用いて行われます。このアプローチは治療の精度を高め、治療成績を向上させ、放射線関連の合併症を減少させるので、画像誘導放射線療は現代の腫瘍学診療において必要な治療法となっています。

画像誘導放射線治療市場の主な促進要因は、多様ながんの有病率の増加と、標的を絞ったがん治療の需要の増加です。さらに、治療中のリアルタイム画像診断の導入が治療効果を高め、画像誘導放射線治療の需要を押し上げています。表面誘導放射線治療は、分注内運動モニタリングや呼吸ゲーティングといった最先端の特性を持つため、最近いくつかの腫瘍施設で広く採用されています。

しかし、画像誘導放射線治療に関連する機器の調達にかかる費用や患者の治療費の高さが、市場の大きな抑制要因となっています。逆に、技術の向上は治療の展望を多様化させ、治癒プロセスを洗練させています。AIとMLの融合は、患者のバイタルと要求に応じて個別化されたがん治療の提供を可能にしています。例えば、膠芽腫に罹患した患者のケースでは、AIベースの線量最適化ソフトウェアが放射線治療の調整に使用されました。これには、脳幹や視神経といった脳の極めて重要な部分を守りながら、最適な線量の放射線を照射し、腫瘍を最大限に抑制することが含まれます。

セグメント別レビュー

画像誘導放射線治療市場は、製品、手技、エンドユーザー、地域に区分されます。製品別では、4D RT、リニアック、MRI誘導放射線治療、ポータルイメージング、CTスキャンに分類されます。手技別では、IMRT（強度変調放射線治療）、定位治療、粒子線治療、その他に分類されます。エンドユーザー別では、病院、独立放射線治療センター、その他に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されています。

主な調査結果

製品別では、リニアックが市場を独占しています。

手技別では、IMRT（強度変調放射線治療）分野が市場をリードしています。

地域別では、北米が2033年までに最も高い収益を上げると予測されています。

本レポートのカスタマイズが可能です。

  • 顧客の関心に応じた企業プロファイルの追加

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 画像誘導放射線療市場：製品別

  • 市場概要
  • 4D RT
  • リニアック
  • MRIガイド下放射線治療
  • ポータルイメージング
  • CTスキャン

第5章 画像誘導放射線治療市場：手技別

  • 市場概要
  • IMRT（強度変調放射線治療）
  • 定位放射線治療
  • 粒子線治療
  • その他

第6章 画像誘導放射線治療市場：エンドユーザー別

  • 市場概要
  • 病院
  • 独立放射線治療センター
  • その他

第7章 画像誘導放射線療市場：地域別

  • 市場概要
  • 北米
    • 主な市場動向と機会
    • 米国の画像誘導放射線治療市場
    • カナダ画像誘導放射線治療市場
    • メキシコ画像誘導放射線治療市場
  • 欧州
    • 主な市場動向と機会
    • フランス画像誘導放射線治療市場
    • ドイツの画像誘導放射線治療市場
    • イタリアの画像誘導放射線治療市場
    • スペイン画像誘導放射線治療市場
    • 英国の画像誘導放射線治療市場
    • その他欧州の画像誘導放射線治療市場
  • アジア太平洋
    • 主な市場動向と機会
    • 中国の画像誘導放射線治療市場
    • 日本の画像誘導放射線治療市場
    • インド画像誘導放射線治療市場
    • 韓国の画像誘導放射線治療市場
    • オーストラリアの画像誘導放射線治療市場
    • その他アジア太平洋の画像誘導放射線治療市場
  • ラテンアメリカ・中東・アフリカ
    • 主な市場動向と機会
    • ブラジルの画像誘導放射線治療市場
    • 南アフリカの画像誘導放射線治療市場
    • サウジアラビアの画像誘導放射線治療市場
    • その他のラテンアメリカ・中東・アフリカの画像誘導放射線治療市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Varian Medical Systems, Inc.
  • Elekta AB, Accuray Incorporated
  • ViewRay, Inc.
  • Siemens Healthineers AG
  • Hitachi, Ltd
  • Brainlab AG
  • MEVION MEDICAL SYSTEMS, INC.
  • C-Rad AB
  • Sumitomo Heavy Industries, Ltd.
  • Philips Healthcare
目次
Product Code: A323701

Image-guided Radiation Therapy Market

The image-guided radiation therapy market was valued at $1.9 billion in 2023 and is projected to reach $3.3 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.

Image-guided radiation therapy is a frequent imaging process used in the treatment of cancer. The therapy involves several imaging techniques such as MRI, PET, and CT scans, which allow for precise targeting of radiation for killing the cancer cells. The precise targeting is performed using the high-quality images generated by imaging technologies. This approach elevates the accuracy of treatment, improves therapy outcomes, and reduces radiation-related complications, making image-guided radiation therapy a necessary procedure in modern oncology practice.

Increase in prevalence of diverse forms of cancers and rise in demand for targeted cancer treatment are the major drivers of the image-guided radiation therapy market. In addition, the deployment of real-time imaging during ongoing treatment sessions has boosted the efficacy of treatment, thereby boosting the demand for image-guided radiation therapy. Surface-guided radiation therapy has recently witnessed widespread adoption in several oncology facilities due to its cutting-edge attributes such as intra-fraction motion monitoring and respiratory gating.

However, the cost associated with procuring instruments related to image-guided radiation therapy, along with the high costs of treatment for the patients, is a major restraint for the market. On the contrary, enhancements in technology are diversifying the prospects of the therapy and refining the healing process. Assimilation of AI and ML is enabling the delivery of personalized cancer treatment according to the vitals and requirements of the patient. For instance, in the case of a patient suffering from glioblastoma, an AI-based dose optimization software was used to tailor the radiation therapy. This included the delivery of optimal dose of radiation, resulting in maximum tumor control while guarding the pivotal parts of the brain such as brainstem and optic nerves.

Segment Review

The image-guided radiation therapy market is segmented into product, procedure, end user, and region. On the basis of product, the market is divided into 4D RT, LINAC, MRI-guided radiotherapy, portal imaging, and CT scanning. By procedure, it is classified into IMRT (intensity modulation radiation therapy), stereotactic therapy, particle therapy, and others. Depending on end user, it is categorized into hospitals, independent radiotherapy centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the LINAC segment dominates the market.

By procedure, the IMRT (intensity modulation radiation therapy) segment is the leader in the market.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global image-guided radiation therapy market include Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, ViewRay, Inc., Siemens Healthineers AG, Hitachi, Ltd, Brainlab AG, MEVION MEDICAL SYSTEMS, INC., C-Rad AB, Sumitomo Heavy Industries, Ltd., and Philips Healthcare. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Product

  • 4D RT
  • LINAC
  • MRI-guided Radiotherapy
  • Portal Imaging
  • CT Scanning

By Procedure

  • IMRT (intensity modulation radiation therapy)
  • Stereotactic Therapy
  • Particle Therapy
  • Others

By End User

  • Hospitals
  • Independent Radiotherapy Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Varian Medical Systems, Inc.
    • Elekta AB, Accuray Incorporated
    • ViewRay, Inc.
    • Siemens Healthineers AG
    • Hitachi, Ltd
    • Brainlab AG
    • MEVION MEDICAL SYSTEMS, INC.
    • C-Rad AB
    • Sumitomo Heavy Industries, Ltd.
    • Philips Healthcare

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: IMAGE-GUIDED RADIATION THERAPY MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. 4D RT
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. LINAC
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. MRI-guided Radiotherapy
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Portal Imaging
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. CT Scanning
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: IMAGE-GUIDED RADIATION THERAPY MARKET, BY PROCEDURE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Procedure
  • 5.2. IMRT (intensity Modulation Radiation Therapy)
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Stereotactic Therapy
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Particle Therapy
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: IMAGE-GUIDED RADIATION THERAPY MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Independent Radiotherapy Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: IMAGE-GUIDED RADIATION THERAPY MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Procedure
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Image-Guided Radiation Therapy Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Procedure
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Image-Guided Radiation Therapy Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Procedure
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Image-Guided Radiation Therapy Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Procedure
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Procedure
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Image-Guided Radiation Therapy Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Procedure
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Image-Guided Radiation Therapy Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Procedure
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Image-Guided Radiation Therapy Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Procedure
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Image-Guided Radiation Therapy Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Procedure
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Image-Guided Radiation Therapy Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Procedure
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Image-Guided Radiation Therapy Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Procedure
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Procedure
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Image-Guided Radiation Therapy Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Procedure
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Image-Guided Radiation Therapy Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Procedure
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Image-Guided Radiation Therapy Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Procedure
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Image-Guided Radiation Therapy Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Procedure
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Image-Guided Radiation Therapy Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Procedure
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Image-Guided Radiation Therapy Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Procedure
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Procedure
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Image-Guided Radiation Therapy Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Procedure
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Image-Guided Radiation Therapy Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Procedure
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Image-Guided Radiation Therapy Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Procedure
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Image-Guided Radiation Therapy Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Procedure
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Varian Medical Systems, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Elekta AB, Accuray Incorporated
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. ViewRay, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Siemens Healthineers AG
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Hitachi, Ltd
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Brainlab AG
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. MEVION MEDICAL SYSTEMS, INC.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. C-Rad AB
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Sumitomo Heavy Industries, Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Philips Healthcare
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments